SILK Laser (ASX:SLA) share price edges lower on quarterly update

The laser clinic company expects a strong rebound in business as COVID-19 restrictions ease

| More on:
A woman lies down with eyes closed as she prepares to receive a cosmetic injectable in her face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The SILK Laser Australia Ltd (ASX: SLA) share price is in the red on Thursday morning after the company announced a resilient first-quarter trading update.

At the time of writing, the SILK Laser share price is down 0.75% to $4.61.

SILK Laser share price down as COVID-19 restrictions bite

SILK Laser delivered a resilient performance over the first quarter ended 30 September. Some highlights include:

  • Network cash sales adjusted for lost trading days up 14% to $23.5 million;
  • Unadjusted network cash sales down 4%;
  • Like-for-like sales adjusted for lost trading days up 2% to $20.4 million; and
  • Unadjusted like-for-like sales down 14%.

SILK was pleased with its FY22 year-to-date performance considering the lost trading days due to closed clinics during COVID-19 lockdowns. It also comes against the backdrop of an exceptionally strong comparable period last year.

The trading update highlighted strong growth across body and injectable categories, with its overall service mix evolving, as planned.

Online sales for SILK's skincare brands surged by 700% to about $189,000, although this came off a low base.

Back in September, the company announced it had completed the acquisition of Australian Skin Clinics (ASC), which pushed the SILK Laser share price higher at the time. The company advised the integration of ASC is on track.

ASC's financial performance was not included in SILK's Q1 sales metrics given its 4 weeks of ownership.

Management commentary

SILK founder and managing director Martin Perelman commented on the first-quarter results, saying:

We are pleased with how the business has performed over the first three months of FY22. While COVID lockdowns again held back sales growth as clinics were forced to close, on an adjusted basis we saw strong momentum in key growth categories, resulting in overall positive like-for-like sales growth. In particular, SILK experienced strong growth across its body and injectables categories, and exceptional growth in online sales of our skincare brands.

What's next for SILK?

SILK is positive on its outlook, citing the majority of NSW clinics achieved the equivalent of approximately two weeks' worth of trading within the first week of opening after lockdowns.

"Cosmetic Injectables, as has happened previously, performed far above expectations driven by strong waitlists and the strength of SILK's injecting teams."

Its service and earnings mix is expected to continue to evolve with a growing position in injectable and body categories. SILK said it will continue to roll out these service offerings across its network.

Despite a challenging trading environment so far in 2021, the SILK Laser share price is up 29% year-to-date.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended SILK Laser Australia Limited. The Motley Fool Australia has recommended SILK Laser Australia Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Oil worker using a smartphone in front of an oil rig.
Share Market News

ASX 200 up strongly while energy shares plummet on ceasefire news

ASX 200 energy shares are tumbling with Karoon Energy and Woodside Energy the biggest fallers.

Read more »

Woman on the phone at a hardware store.
Broker Notes

Up 21% this year, how much further upside does Macquarie tip for Metcash shares?

Metcash shares tick many boxes for investors.

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them.
Opinions

Why I'd buy these top ASX 200 shares next

Growing businesses are compelling. These two are growing significantly.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

A much better session is expected for Aussie investors today.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the week this Monday.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Guess which popular ASX 200 stock Bell Potter just downgraded

Let's see what the broker is saying on this blue chip.

Read more »

Crude oil barrels rocketing.
ETFs

Why did the BetaShares Crude Oil ETF just spike 4%?

This ETF is attracting buyers in today's seller's market.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »